Megavitamin and orthomolecular therapy in psychiatry.
D000368:Aged; D000437:Alcoholism / Q000188:drug therapy; D001205:Ascorbic Acid / Q000627:therapeutic use; D001361:Avitaminosis / Q000150:complications / Q000188:drug therapy; D002648:Child; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D009243:NAD / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D011570:Psychiatry; D011736:Pyridoxine / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000188:drug therapy; D014805:Vitamin B 12 / Q000627:therapeutic use; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014815:Vitamins; D009243:NAD; D005492:Folic Acid; D011736:Pyridoxine; D014805:Vitamin B 12; D001205:Ascorbic Acid